share_log

12 Health Care Stocks Moving In Tuesday's After-Market Session

Benzinga ·  Jul 5, 2023 05:37

Gainers

  • Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 11.8% to $0.52 during Tuesday's after-market session. The company's market cap stands at $13.5 million.
  • GRI Bio (NASDAQ:GRI) stock moved upwards by 10.35% to $4.9. The company's market cap stands at $14.3 million.
  • RVL Pharmaceuticals (NASDAQ:RVLP) stock rose 7.97% to $0.59. The market value of their outstanding shares is at $59.0 million.
  • MSP Recovery (NASDAQ:LIFW) shares increased by 7.93% to $0.36. The market value of their outstanding shares is at $26.3 million.
  • Processa Pharma (NASDAQ:PCSA) stock moved upwards by 7.67% to $0.56. The market value of their outstanding shares is at $13.7 million.
  • MoonLake (NASDAQ:MLTX) shares increased by 6.58% to $54.04. The company's market cap stands at $2.7 billion.

Losers

  • Amneal Pharmaceuticals (NYSE:AMRX) shares declined by 14.8% to $2.6 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 116.0K shares, which is 11.8 percent of its average volume over the last 100 days. The company's market cap stands at $398.6 million.
  • Comera Life Sciences (NASDAQ:CMRA) shares fell 9.41% to $0.47. This security traded at a volume of 421.7K shares come close, making up 1012.3% of its average volume over the last 100 days. The company's market cap stands at $10.5 million.
  • Coeptis Therapeutics (NASDAQ:COEP) shares fell 8.83% to $1.55. The market value of their outstanding shares is at $36.7 million.
  • SHL Telemedicine (NASDAQ:SHLT) stock decreased by 8.19% to $9.98.
  • LifeMD (NASDAQ:LFMD) shares fell 7.73% to $4.42. The company's market cap stands at $148.1 million.
  • Vaccitech (NASDAQ:VACC) shares decreased by 6.76% to $2.07. The market value of their outstanding shares is at $79.4 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment